Philip Scheltens, M.D., Ph.D.

Alzheimer Center Amsterdam; Managing Partner, LSP Dementia Fund; Honorary Professor, King's College London.

Contact Information

Philip Scheltens, M.D., Ph.D.
Amsterdam, Netherlands

Professional Information

Professor
Alzheimer Center Amsterdam; Managing Partner, LSP Dementia Fund; Honorary Professor, King's College London.
http://www.alzheimercentrum.nl

Financial Disclosure

Member reports the following financial or other potential conflicts of interest:
[Last updated: Dec 1, 2020]

Dr Scheltens has received consultancy fees (paid to the institution) from AC Immune, Alkermes, Alnylam, Alzheon, Anavex, Biogen, Brainstorm Cell, Cortexyme, Denali, EIP, ImmunoBrain Checkpoint, GemVax, Genentech, Green Valley, Novartis, Novo Noridisk, PeopleBio, Renew LLC, Roche. He is PI of studies with AC Immune, CogRx, FUJI-film/Toyama, IONIS, UCB, Vivoryon. He serves on the board of the Brain Research Center.